5.25
price down icon2.60%   -0.14
after-market Dopo l'orario di chiusura: 5.27 0.02 +0.38%
loading

Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
14.57%
8.5052
7.4233 12.44 14.97 6.1835
Operating Income/Loss
2.48%
-10.17
-10.43 -16.14 -18.01 -9.3939
Nonoperating Income/Loss
19.39%
0.4014
0.498 1.0246 1.1602 1.3117
Income/Loss From Continuing Operations Before Tax
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Income/Loss From Continuing Operations After Tax
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Net Income/Loss
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.26%
60.05
59.89 59.53 59.41 59.41
Diluted Average Shares
0.26%
60.05
59.89 59.53 59.41 59.41
Basic Earnings Per Share
5.88%
-0.16
-0.17 -0.25 -0.28 -0.14
Diluted Earnings Per Share
5.88%
-0.16
-0.17 -0.25 -0.28 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):